Kosan Biosciences (MM)
   
To register click here

Kosan Biosciences Stock Price KOSN

Company Description : A cancer therapeutics company focused on advancing two new classes of anticancer agents through clinical development: heat shock protein 90, or Hsp90, inhibitors and epothilones. url: www.kosan.com

Name:
Kosan Biosciences (MM)
Symbol:
NASDAQ:KOSN
Stock Market:
NASDAQ Stock Market
Type:
Common Stock
ISIN:
Description:
 Change (p)Change (%)CurBidAskHighLowOpenVolumeTimeA
0.00.005.63
To register Click hereRegister for free Kosan Biosciences stock prices.

Kosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breas : Data Presented at ASCO Show 26% Partial Response, 63% Clinical Benefit Incidence HAYWARD, Calif., June 3 /PRNewswire-FirstCall/ -- Kosan Biosciences Incorporated (NASDAQ:KOSN) today announced that its lead Hsp90 inhibitor...

Free Kosan Biosciences Stock Charts

Kosan Biosciences Historical Stock Chart
Kosan Biosciences Historical Stock Chart
Kosan Biosciences Monthly Stock Chart
Kosan Biosciences Monthly Stock Chart
Kosan Biosciences Intraday stock chart
Kosan Biosciences Intraday stock chart

To register Click hereRegister for FREE streaming stock charts featuring overlays, annotations and more than 80 different studies including Level 2 Scope and Average True Range.

Get the Latest Kosan Biosciences stock Price, quotes, trades and FREE Kosan Biosciences stock charts, company information, annual reports, market news and announcements from ADVFN. We offer Intraday and historical stock prices for Kosan Biosciences (KOSN) and other NASDAQ Stock Market listed companies as well as company financials, Level 2 Data and the latest investor information from our stock market Message Boards.

Kosan Biosciences News

Latest Kosan Biosciences News Headlines
DateTimeSource
Headline
06/03/20089:00AMPRNUSKosan's Lead Hsp90 Inhibitor, Tanespimycin, Shows High Level of Activity in Trastuzumab Resistant/Refractory HER2-Positive Breas
06/03/20089:33AMTFNFKosan Biosciences drug shows high level of antitumor activity in Phase II trial
05/29/20089:05AMTFNFBristol-Myers to acquire Kosan for $190M; deal carries plus 200% premium
05/20/20086:00AMPRNUSKosan Appoints Pamela S. Cohen, M.D., as Chief Medical Officer
05/14/20086:00AMPRNUSKosan Announces Data Presentations at ASCO 2008 Annual Meeting
05/06/20084:00PMPRNUSKosan Biosciences to Present at the Leerink Swann Solid Tumors Roundtable Conference
05/01/20084:00PMPRNUSKosan Announces First Quarter 2008 Financial Results
04/25/20086:00AMPRNUSKosan Announces May 1, 2008 Conference Call and Webcast of First Quarter 2008 Financial Results
04/16/20084:09PMPRNUSKosan Presents Preclinical Data on Novel Third-Generation Hsp90 Inhibitors at AACR
04/16/20084:06PMPRNUSKosan Presents Preclinical Data on Nuclear Export Inhibitors, Novel Anticancer Agents, at AACR
04/14/20086:00AMPRNUSKosan Initiates Phase 2 Trial of Epothilone KOS-1584 in Non-Small Cell Lung Cancer
03/18/20087:08PMTFNFKosan Biosciences to cut workforce by 37%

Kosan Biosciences Company Information

 Sector  Turnover (m)  Profit (m)  EPS - Basic  PE ratio  Mkt Cap (m)  NMS 
  0.00 0.00   0.0 N/A
To register Click hereRegister for FREE access to the latest Kosan Biosciences company information and fundamental data for other USA Common Stock companies. More than 100 separate statistics including accounts payable / sales and inventory / sales.

Latest Kosan Biosciences Stock Trade

 Type  Size  Price  Date  Tr.Time  Units 
      USD


 



PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2008 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs
ADDITIONAL SERVICES AVAILABLE FROM ADVFN
Upgrade - Click here for more information on ADVFN premium services Money Words - ADVFN Financial Glossary Investor Training ADVFN Financial Bookshop Online Training Academy
31 site:2us nasdaq kosn080720 07:21 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2005 | 2007 )